검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Allogeneic invariant Natural Killer T (Allogeneic invariant Natural Killer T, Allogeneic invariant Natural Killer T (iNKT) Cells (AgenT-797), iNKT) ImmunityBio, Inc.·Acute Respiratory Distress Syndrom… ORR 14% |
|---|---|
Overview Program | Allogeneic invariant Natural Killer T (iNKT) Cells (AgenT-797) |
Overview Company | ImmunityBio, Inc. |
Overview Modality | CGT |
Overview Target | Acute Respiratory Distress Syndrome |
Overview Indication | Acute Respiratory Distress Syndrome; Severe Community-Acquired Pneum |
Overview Phase | PHASE_2 |
Overview Status | DISCONTINUED |
Toxicology Major finding | Polygonatum sibiricum Polysaccharide and αGalCer Synergistically Act as Dual Adjuvants to Enhance Humoral and Cellular Immune Responses.. Adjuvants are indispensable for subunit vaccines. However, the development of safe and effective adjuvants remains a major challenge. Polysaccharides derived from traditional Chinese medicine (TCM) have recently emerged as promising sources of novel vaccin… |
Toxicology CRS | Reported |
Clinical Primary efficacy | ORR 14% |
Clinical ORR | 14% |
Clinical Result source | ClinicalTrials.gov NCT04011033 |
Clinical Data Tier / Score | A · 15 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 5월 22일 (52일 전 · 갱신 권장) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Allogeneic invariant Natural Killer T (Allogeneic invariant Natural Killer T, Allogeneic invariant Natural Killer T (iNKT) Cells (AgenT-797), iNKT) ImmunityBio, Inc.·Acute Respiratory Distress Syndrom… ORR 14% |
|---|---|
Overview Program | Allogeneic invariant Natural Killer T (iNKT) Cells (AgenT-797) |
Overview Company | ImmunityBio, Inc. |
Overview Modality | CGT |
Overview Target | Acute Respiratory Distress Syndrome |
Overview Indication | Acute Respiratory Distress Syndrome; Severe Community-Acquired Pneum |
Overview Phase | PHASE_2 |
Overview Status | DISCONTINUED |
Toxicology Major finding | Polygonatum sibiricum Polysaccharide and αGalCer Synergistically Act as Dual Adjuvants to Enhance Humoral and Cellular Immune Responses.. Adjuvants are indispensable for subunit vaccines. However, the development of safe and effective adjuvants remains a major challenge. Polysaccharides derived from traditional Chinese medicine (TCM) have recently emerged as promising sources of novel vaccin… |
Toxicology CRS | Reported |
Clinical Primary efficacy | ORR 14% |
Clinical ORR | 14% |
Clinical Result source | ClinicalTrials.gov NCT04011033 |
Clinical Data Tier / Score | A · 15 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 5월 22일 (52일 전 · 갱신 권장) |
추천 비교
추천 비교